Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Arrowhead and Shire enter agreement to develop peptide-targeted therapeutics

Dec. 20, 2012

Co-development agreement reached for NTCell for Parkinson's disease

Dec. 19, 2012

Lorus Therapeutics and Brock University to develop novel anticancer drugs

Dec. 19, 2012

Lundbeck to divest non-core products to Recordati

Dec. 18, 2012

MedImmune to develop therapies against serious bacterial infections

Dec. 18, 2012

Phenex collaborates with Janssen on autoimmune and chronic inflammatory disorders

Dec. 18, 2012

Evotec licenses portfolio of NMDA antagonists to Janssen

Dec. 18, 2012

Eisai and UCL partner to develop new treatments for neurological diseases

Dec. 17, 2012

Milestone reached in DuoBody platform collaboration

Dec. 14, 2012

Fred Hutchinson and GSK partner to develop muscular dystrophy therapeutics

Dec. 13, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...